Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.

Blandamura S, Alessandrini L, Bertorelle R, Simonato F, Guzzardo V, Valentini E, Angriman I, Fassina A.

Pathol Res Pract. 2014 Jun;210(6):392-6. doi: 10.1016/j.prp.2014.01.019. Epub 2014 Mar 5.

PMID:
24674454
2.

Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).

Agaimy A, Otto C, Braun A, Geddert H, Schaefer IM, Haller F.

Int J Clin Exp Pathol. 2013 Aug 15;6(9):1839-46. eCollection 2013.

3.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA.

J Clin Oncol. 2003 Dec 1;21(23):4342-9.

PMID:
14645423
4.

Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.

Cho S, Kitadai Y, Yoshida S, Tanaka S, Yoshihara M, Yoshida K, Chayama K.

Int J Oncol. 2006 Jun;28(6):1361-7.

PMID:
16685437
5.

Coexistence of gastrointestinal stromal tumors and gastric adenocarcinomas.

Yan Y, Li Z, Liu Y, Zhang L, Li J, Ji J.

Tumour Biol. 2013 Apr;34(2):919-27. doi: 10.1007/s13277-012-0627-5. Epub 2013 Jan 3.

PMID:
23283817
6.

Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.

Søreide K, Sandvik OM, Søreide JA, Gudlaugsson E, Mangseth K, Haugland HK.

Clin Transl Oncol. 2012 Aug;14(8):619-29. doi: 10.1007/s12094-012-0851-x. Epub 2012 Jul 18.

PMID:
22855146
7.

Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.

Miettinen M, Sobin LH, Lasota J.

Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99.

PMID:
19440146
8.

Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors.

Haller F, Happel N, Schulten HJ, von Heydebreck A, Schwager S, Armbrust T, Langer C, Gunawan B, Doenecke D, Füzesi L.

Mod Pathol. 2007 Oct;20(10):1103-11. Epub 2007 Aug 3.

9.

Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.

Wang C, Jin MS, Zou YB, Gao JN, Li XB, Peng F, Wang HY, Wu ZD, Wang YP, Duan XM.

Scand J Gastroenterol. 2013 Sep;48(9):1055-65. doi: 10.3109/00365521.2013.816770. Epub 2013 Jul 17.

PMID:
23862765
10.

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.

Wasag B, Debiec-Rychter M, Pauwels P, Stul M, Vranckx H, Oosterom AV, Hagemeijer A, Sciot R.

Mod Pathol. 2004 Aug;17(8):889-94.

11.

The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.

Penzel R, Aulmann S, Moock M, Schwarzbach M, Rieker RJ, Mechtersheimer G.

J Clin Pathol. 2005 Jun;58(6):634-9.

12.

Clinicopathological and molecular aspects of foregut gastrointestinal stromal tumours.

Chen J, Gundara JS, Haddad R, Schiavone V, Meldrum C, Samra JS, Gill AJ, Hugh TJ.

ANZ J Surg. 2014 Jan-Feb;84(1-2):52-8. doi: 10.1111/ans.12011. Epub 2012 Nov 22.

PMID:
23171083
13.

Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.

Debiec-Rychter M, Wasag B, Stul M, De Wever I, Van Oosterom A, Hagemeijer A, Sciot R.

J Pathol. 2004 Apr;202(4):430-8.

PMID:
15095270
14.

KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.

Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD.

Am J Surg Pathol. 2004 Jul;28(7):889-94.

PMID:
15223958
15.

Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles.

Subramanian S, West RB, Corless CL, Ou W, Rubin BP, Chu KM, Leung SY, Yuen ST, Zhu S, Hernandez-Boussard T, Montgomery K, Nielsen TO, Patel RM, Goldblum JR, Heinrich MC, Fletcher JA, van de Rijn M.

Oncogene. 2004 Oct 14;23(47):7780-90.

PMID:
15326474
16.

Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.

Ding J, Sun P, Cai XY, Fei SH, Wu J, Qi YK, Liu ZB, Yuan L, He YJ, Song H, Chen WX.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):9076-80. eCollection 2014.

17.

[Translational research and diagnosis in GIST].

Wardelmann E.

Pathologe. 2012 Nov;33 Suppl 2:273-7. doi: 10.1007/s00292-012-1682-9. Review. German.

PMID:
22968735
18.

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.

Emile JF, Brahimi S, Coindre JM, Bringuier PP, Monges G, Samb P, Doucet L, Hostein I, Landi B, Buisine MP, Neuville A, Bouché O, Cervera P, Pretet JL, Tisserand J, Gauthier A, Le Cesne A, Sabourin JC, Scoazec JY, Bonvalot S, Corless CL, Heinrich MC, Blay JY, Aegerter P.

Med Oncol. 2012 Sep;29(3):1765-72. doi: 10.1007/s12032-011-0074-y. Epub 2011 Sep 28.

PMID:
21953054
19.
20.

Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.

Prakash S, Sarran L, Socci N, DeMatteo RP, Eisenstat J, Greco AM, Maki RG, Wexler LH, LaQuaglia MP, Besmer P, Antonescu CR.

J Pediatr Hematol Oncol. 2005 Apr;27(4):179-87. Review.

PMID:
15838387

Supplemental Content

Support Center